Skip to content
The Nexus
DossierENTITY

Anvisa

Coverage of Anvisa in the Nexus archive.

Earliest in view: Jul 9 · 16:20 UTCMost recent: Jul 28 · 06:24 UTC
Co-mentioned in this coverage
Brazilplace2lenacapavirtopic1HIV-preventiontopic1Paraguayplace1Unicamp toxicology centreorganization1tirzepatidetopic1weight-loss penstopic1
Recent coverage
  • HEALTHJul 28 · 06:24 UTCTHE RIO TIMES
    Brazil Moves to Add a Twice-Yearly HIV-Prevention Shot to Its Public Health System

    Brazil is adding lenacapavir, a twice-yearly HIV-prevention injection, to its public health system. The drug, approved by health regulator Anvisa in January 2026, replaces daily pills and is administered subcutaneously for adults and adolescents.

  • HEALTHJul 9 · 16:20 UTCTHE RIO TIMES
    Brazil Says Paraguay’s Weight-Loss Pens Are Not the Same Drug

    Brazil's medicines regulator, Anvisa, stated that Paraguay's weight-loss pens are not equivalent to the drug tirzepatide. Tests by Unicamp's toxicology centre confirmed the presence and concentration of tirzepatide in smuggled vials but did not assess impurities, contaminants, or sterility.